MedTrace Logo

Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery

NCT07347665 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-24

No results posted yet for this study

Summary

RESCUE-M2O trial is a prospective, open label, blinded endpoint (PROBE), two-arm, randomized, controlled, post-market study to assess the efficacy and safety of endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.

Conditions

  • Endovascular Therapy
  • Acute Ischemic Stroke
  • Acute Ischemic Stroke (AIS) Related to a Distal Occlusion

Interventions

PROCEDURE

Endovascular therapy

Endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.

Sponsors & Collaborators

  • Hyogo Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2028-03-31
Completion
2030-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07347665 on ClinicalTrials.gov